Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein

Liu YC, Yeh CT, Lin KH. Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies. Cells. 2020;9:1331.

Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q, et al. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 2021;11:3489–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19:26–44.

Article  PubMed  Google Scholar 

Cheng Z, Li X, Ding J. Characteristics of liver cancer stem cells and clinical correlations. Cancer Lett. 2016;379:230–8.

Article  CAS  PubMed  Google Scholar 

Nio K, Yamashita T, Kaneko S. The evolving concept of liver cancer stem cells. Mol Cancer. 2017;16:4.

Article  PubMed  PubMed Central  Google Scholar 

Xiang Y, Yang T, Pang BY, Zhu Y, Liu YN. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int. 2016; 2016: 7614971.

Lv D, Chen L, Du L, Zhou L, Tang H. Emerging Regulatory mechanisms involved in Liver Cancer Stem Cell properties in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021;9:691410.

Article  PubMed  PubMed Central  Google Scholar 

Sukowati CH, El-Khobar K, Jasirwan COM, Kurniawan J, Gani RA. Stemness markers in hepatocellular carcinoma of Eastern vs. western population: etiology matters? Ann Hepatol. 2024;29:101153.

Article  CAS  PubMed  Google Scholar 

Fang X, Yan Q, Liu S, Guan XY. Cancer Stem cells in Hepatocellular Carcinoma: intrinsic and extrinsic molecular mechanisms in Stemness Regulation. Int J Mol Sci. 2022; 23.

Harputluoglu M, Carr BI, Hepatitis B. Before and after Hepatocellular Carcinoma. J Gastrointest Cancer. 2021;52:1206–10.

Article  PubMed  Google Scholar 

Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol. 2022;28:3793–802.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:435–50.

Article  PubMed  PubMed Central  Google Scholar 

Jia L, Gao Y, He Y, Hooper JD, Yang P. HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol Res. 2020;159:104992.

Article  CAS  PubMed  Google Scholar 

Wang M, Xi D, Ning Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017;11:171–80.

Article  PubMed  Google Scholar 

Yamashita T, Nault JC. Stemness of liver cancer: from hepatitis B virus to wnt activation. J Hepatol. 2016;65:873–5.

Article  PubMed  Google Scholar 

Dong KS, Chen Y, Yang G, Liao ZB, Zhang HW, Liang HF, et al. TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p. Oncogene. 2020;39:1807–20.

Article  CAS  PubMed  Google Scholar 

Dai XM, Huang T, Yang SL, Zheng XM, Chen GG, Zhang T. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma. Dis Markers. 2017; 2017: 8495326.

Yeh CT, Kuo CJ, Lai MW, Chen TC, Lin CY, Yeh TS, et al. CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer. 2009;9:324.

Article  PubMed  PubMed Central  Google Scholar 

Su H, Han C, He Y, Liang T, Mo S, Yang C, et al. Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi. Ann Transl Med. 2021;9:1780.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong F, Li Q, Zhang F, Li X, You H, Pan X, et al. Sirtuins as potential therapeutic targets for Hepatitis B Virus infection. Front Med (Lausanne). 2021;8:751516.

Article  PubMed  Google Scholar 

Kong F, Zhang F, Liu X, Qin S, Yang X, Kong D, et al. Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target. Cell Commun Signal. 2021;19:82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You H, Qin S, Zhang F, Hu W, Li X, Liu D, et al. Regulation of pattern-recognition receptor signaling by HBX during Hepatitis B Virus infection. Front Immunol. 2022;13:829923.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You H, Wang X, Ma L, Zhang F, Zhang H, Wang Y, et al. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Commun Signal. 2023;21:70.

Article  PubMed  PubMed Central  Google Scholar 

Kong F, You H, Kong D, Zheng K, Tang R. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis. Virol J. 2019;16:73.

Article  PubMed  PubMed Central  Google Scholar 

Sivasudhan E, Blake N, Lu Z, Meng J, Rong R. Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review. Cells. 2022;11:741.

Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, et al. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatol Int. 2022;16:741–54.

Article  PubMed  Google Scholar 

Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y, et al. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway. Int J Cancer. 2017;140:1346–55.

Article  CAS  PubMed  Google Scholar 

Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 2011;71:3701–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahodantin J, Lekbaby B, Bou Nader M, Soussan P, Kremsdorf D. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells. Carcinogenesis. 2020;41:358–67.

Article  CAS  PubMed  Google Scholar 

Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, et al. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology. 2012;55:108–20.

Article  CAS  PubMed  Google Scholar 

Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, et al. Hepatitis B virus X protein promotes the stem-like properties of OV6(+) cancer cells in hepatocellular carcinoma. Cell Death Dis. 2017;8:e2560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma. Int J Mol Sci. 2023;24:1417.

Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med. 2014;11:182–90.

CAS  PubMed  PubMed Central  Google Scholar 

You H, Li Q, Kong D, Liu X, Kong F, Zheng K, et al. The interaction of canonical Wnt/beta-catenin signaling with protein lysine acetylation. Cell Mol Biol Lett. 2022;27:7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duspara K, Bojanic K, Pejic JI, Kuna L, Kolaric TO, Nincevic V, et al. Targeting the wnt signaling pathway in Liver Fibrosis for Drug options: an update. J Clin Transl Hepatol. 2021;9:960–71.

PubMed  PubMed Central  Google Scholar 

Hsieh A, Kim HS, Lim SO, Yu DY, Jung G. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/beta-catenin signaling. Cancer Lett. 2011;300:162–72.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif